HK1049151A1 - 四氫化苯並吲衍生物、其製備方法和用作5-ht7受體拮抗劑的用途 - Google Patents
四氫化苯並吲衍生物、其製備方法和用作5-ht7受體拮抗劑的用途Info
- Publication number
- HK1049151A1 HK1049151A1 HK02109226.5A HK02109226A HK1049151A1 HK 1049151 A1 HK1049151 A1 HK 1049151A1 HK 02109226 A HK02109226 A HK 02109226A HK 1049151 A1 HK1049151 A1 HK 1049151A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tetrahydrobenzindolone
- derivatives
- preparation
- receptor antagonists
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9924628.2A GB9924628D0 (en) | 1999-10-18 | 1999-10-18 | Novel compounds |
GB0006168A GB0006168D0 (en) | 2000-03-14 | 2000-03-14 | Novel compounds |
GB0018952A GB0018952D0 (en) | 2000-08-03 | 2000-08-03 | Novel compounds |
PCT/EP2000/010149 WO2001029029A1 (en) | 1999-10-18 | 2000-10-13 | Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1049151A1 true HK1049151A1 (zh) | 2003-05-02 |
Family
ID=27255596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02109226.5A HK1049151A1 (zh) | 1999-10-18 | 2002-12-19 | 四氫化苯並吲衍生物、其製備方法和用作5-ht7受體拮抗劑的用途 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1222185A1 (zh) |
JP (1) | JP2003512372A (zh) |
AU (1) | AU1025601A (zh) |
HK (1) | HK1049151A1 (zh) |
WO (1) | WO2001029029A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2392340T3 (es) * | 2002-03-29 | 2012-12-07 | Mitsubishi Tanabe Pharma Corporation | Remedio para los trastornos del sueño |
WO2005040169A2 (en) | 2003-09-17 | 2005-05-06 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds as serotonin receptor modulators |
US7598255B2 (en) | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
EP1875899A1 (en) * | 2006-06-29 | 2008-01-09 | Laboratorios Del Dr. Esteve, S.A. | Use of 5HT7 receptor agonists for the treatment of pain |
AU2018215466B2 (en) * | 2017-02-03 | 2022-03-10 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule antagonists of SUMO related modification of CRMP2 and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69733427T2 (de) * | 1996-06-28 | 2006-04-27 | Meiji Seika Kaisha Ltd. | Tetrahydrobezindol derivate |
DE69829317T2 (de) * | 1997-12-25 | 2006-04-06 | Meiji Seika Kaisha Ltd. | Tetrahydrobenzindol-derivate |
-
2000
- 2000-10-13 EP EP00971384A patent/EP1222185A1/en not_active Withdrawn
- 2000-10-13 JP JP2001531828A patent/JP2003512372A/ja active Pending
- 2000-10-13 WO PCT/EP2000/010149 patent/WO2001029029A1/en not_active Application Discontinuation
- 2000-10-13 AU AU10256/01A patent/AU1025601A/en not_active Abandoned
-
2002
- 2002-12-19 HK HK02109226.5A patent/HK1049151A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU1025601A (en) | 2001-04-30 |
JP2003512372A (ja) | 2003-04-02 |
EP1222185A1 (en) | 2002-07-17 |
WO2001029029A1 (en) | 2001-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1048999A1 (zh) | 氮雜䓬吲衍生物,它們的製備和應用 | |
HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
AU2167002A (en) | Indoline derivatives and their use as 5-ht2 receptor ligands | |
PL351312A1 (en) | New compounds, their preparation and use | |
HUP0301671A3 (en) | 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists, process for their preparation and their use | |
SI1035115T1 (en) | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists | |
AU4667101A (en) | Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands | |
IL153708A0 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
IL152700A0 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists | |
IL145150A0 (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
HK1030939A1 (en) | Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists | |
PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
IL135451A0 (en) | 3-amino-3-arylpropan-1-ol derivatives, their preparation and use | |
HUP0100926A3 (en) | Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists | |
HUP0203627A3 (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them | |
PL351794A1 (en) | 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists | |
AU3811300A (en) | Sulfonamide derivatives as 5-ht7 receptor antagonists | |
HUP0201810A3 (en) | Sootepenseone and its derivatives, their preparation and use as medicament | |
AUPQ570100A0 (en) | Beta-alanine derivatives and their use as receptor antagonists | |
HK1049151A1 (zh) | 四氫化苯並吲衍生物、其製備方法和用作5-ht7受體拮抗劑的用途 | |
IL135452A0 (en) | 3-amino-3-arylpropan-1-ol derivatives, their preparation and use | |
EP1169042A4 (en) | DIBENZO-AZEPINE DERIVATIVES AS ANTAGONISTS OF THE ALPHA V INTEGRIN RECEPTOR | |
HUP0204084A3 (en) | Novel heteroaryl derivatives, their preparation and use | |
IL143451A0 (en) | NEW- β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS | |
ZA9810425B (en) | Novel heterocyclically substituted Ó-hydroxycarboxylic acid derivatives, their preparation and use as endothelin receptor antagonists. |